Sitc
Highly Engaged Employees
Membership Organizations · Wisconsin, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
555 E Wells St Ste 1100, Milwaukee, Wisc...Phone Number
(414) 271-2456Website
www.sitcancer.orgRevenue
$5.2 MillionIndustry
About Sitc
Sitc Org Chart
Is Sitc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Sitc recently announced quarterly report
Funding: Get notified immidiatlly once Sitc has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sitc launches new products
Sitc, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sitc has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Sitc
Check out if Sitc is spiking on competitors!
Click to see if Sitc had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Sitc
Compare insights from companies similar to Sitc, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sitc is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Sitc is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Sitc.
Sitc Tech Stack
A closer look at the technologies used by Sitc
Most Recent Scoops
Sitc News & Media
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line patients with surgically resectable cancers Infinitopes' proprietary vector delivery system reliably triggers durable T-cell protection, which halted or delayed tumour progression in industry standard preclinical mouse models, without checkpoint inhibitor co-treatment The Company's approach utiliseInfinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line patients with surgically resectable cancers Infinitopes' proprietary vector delivery system reliably triggers durable T-cell protection, which halted or delayed tumour progression in industry standard preclinical mouse models, without checkpoint inhibitor co-treatment The Company's approach utiliseBPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and BRG399 at SITC 2024
BOSTON--(BUSINESS WIRE)-- #SITC--BPGbio to present transformative immuno-oncology research on BPM31510 and BRG399 at SITC 2024.Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024
Top Membership Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sitc
The Society for Immunotherapy of Cancer (SITC) is a leading member-driven organization focused on advancing the science and application of cancer immunotherapy. It offers a range of educational programs, resources, and networking opportunities for professionals in the field, including annual meetings, webinars, and workshops. SITC serves a diverse... Read More